Boar taint affects meat from intact male pigs, driving surgical castration. Immunocastration offers a welfare-superior alternative that is approved and used in dozens of countries worldwide.
The boar taint problem illustrates how a relatively minor consumer concern — an offensive odor in a small percentage of pork — has driven a welfare harm affecting hundreds of millions of animals. Surgical castration of piglets to prevent taint causes acute pain and prolonged post-operative pain that is well documented. Immunocastration achieves the same taint prevention with far lower welfare cost — the injections are less invasive than surgery, and the approach avoids the anesthesia challenges that limit pain management in young piglets. The primary barrier to adoption is inertia, regulatory status in some markets, and incomplete consumer education.